Why is Nestmedic investing into business development in Scandinavia? What will be the next regions of expansion for the Wrocław-based company and what are the sources of financing? – these and other questions are answered by Patrycja Wizińska-Socha, M.D., CEO at Nestmedic S.A., in an interview on Inwestorzy.tv (TV channel for investors).
The contract with Dignio AS Aksjeselskap opens a very developed and ready market for us. Telemedicine solutions are regularly used by 75% of Norwegian hospitals and in the northern parts of the country it is 100%, says Nestmedic’s CEO.
Patrycja Wizińska-Socha also points out that 2018 will be the year of vigorous work on new implementations and commercialization of Pregnabit in selected markets, including the United Arab Emirates, India and Germany. CEO says that the product has been verified by the healthcare market and the company is getting closer to signing first larger-scale commercial contracts outside Poland.
The interview is available at: http://inwestorzy.tv/wizinska-socha-nestmedic-rynek-skandynawski-jest-bardzo-obiecujacym-rynkiem-dla-telemedycyny/
